Glaucoma: all 1,844 studies

Page 19 of 19. Open to participants first (233), then studies with results posted, then the rest; newest registration first within each.

• The Canadian Glaucoma StudyTerminatedNCT00262626Not applicable
• Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering SurgeryWithdrawnNCT00238563Not applicable
• Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular PressureCompletedNCT00230763Phase 3
• African Descent and Glaucoma Evaluation StudyStatus unknownNCT00221923
• Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular HypertensionCompletedNCT00219596Phase 3
• The Results of Ahmed Valve OperationsStatus unknownNCT00193960
• Magnetic Resonance Imaging of Patients With Normal Tension GlaucomaCompletedNCT00175786
• Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular HypertensionCompletedNCT00168363Phase 3
• Memantine in Patients With Chronic GlaucomaCompletedNCT00168350Phase 3
• A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaCompletedNCT00159653Phase 3
• The Genetic Study of Primary Angle-Closure GlaucomaStatus unknownNCT00155857
• Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With DorzolamideStatus unknownNCT00152932Not applicable
• A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular HypertensionCompletedNCT00150267Phase 3
• SOLX Titanium Sapphire Laser for TrabeculoplastyCompletedNCT00145535Phase 3
• Corneal Versus Conjunctival Delivery Using a Delivery DeviceWithdrawnNCT00143429Phase 2
• Memantine in Patients With Chronic GlaucomaCompletedNCT00141882Phase 3
• Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.CompletedNCT00140062Phase 4
• A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ GlaucomaCompletedNCT00140049Phase 4
• Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to TravatanCompletedNCT00121147Not applicable
• Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)CompletedNCT00108017Phase 3
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00069719Phase 2
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00069706Phase 2
• Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular HypertensionCompletedNCT00061542Phase 3
• A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00061529Phase 3
• Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular HypertensionCompletedNCT00061516Phase 3
• Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT00061503Phase 4
• A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNCT00051194Phase 2
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure GlaucomaCompletedNCT00051181Phase 3
• A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)CompletedNCT00051155Phase 3
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)CompletedNCT00051142Phase 3
• Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32TerminatedNCT00047606Phase 4
• Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98CompletedNCT00047593Phase 3
• Study of TRAVATAN in Subjects With Iris Pigmentation ChangesTerminatedNCT00047554
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70CompletedNCT00047541Phase 3
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41CompletedNCT00047528Phase 3
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69CompletedNCT00047515Phase 3
• Cause of Pigment Dispersion SyndromeCompletedNCT00005919
• Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and LensCompletedNCT00001161
• Pigment Dispersion Syndrome With and Without GlaucomaCompletedNCT00001152
• Collaborative Initial Glaucoma Treatment Study (CIGTS)Status unknownNCT00000149Phase 3
• Advanced Glaucoma Intervention Study (AGIS)Status unknownNCT00000148Phase 3
• Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)CompletedNCT00000144Phase 3
• Early Manifest Glaucoma Trial (EMGT)Status unknownNCT00000132Phase 3
• Fluorouracil Filtering Surgery Study (FFSS)CompletedNCT00000122Phase 3

← Glaucoma overview